Metraipolis › archive › dc_b152ea3592f0

Development of CpG-Depleted CFTR Plasmid-Based Nanoparticles for Nonviral Gene Therapy in Lung Cystic Fibrosis Disease — Europe PMC PMID:41867086

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41867086
DOI
10.1002/jgm.70087
License (as archived)
solo-consultazione
Archived
2026-11-05T11:31:51.471Z
SHA-256 of the archived text
0d0accb36ff5c91daceb93bd8f7884caa738d38d6b0d3e015c96d4d943c5dc38
Stable URL of this page
https://metraipolis.com/documento/dc_b152ea3592f0

How to cite

Development of CpG-Depleted CFTR Plasmid-Based Nanoparticles for Nonviral Gene Therapy in Lung Cystic Fibrosis Disease — Europe PMC PMID:41867086 — Europe PMC (en), https://europepmc.org/article/MED/41867086 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b152ea3592f0 (Metraipolis archive dc_b152ea3592f0, sha256 0d0accb36ff5c91daceb93bd8f7884caa738d38d6b0d3e015c96d4d943c5dc38)
BibTeX
@misc{dcb152ea3592f0,
  title = {Development of CpG-Depleted CFTR Plasmid-Based Nanoparticles for Nonviral Gene Therapy in Lung Cystic Fibrosis Disease — Europe PMC PMID:41867086},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41867086},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b152ea3592f0; sha256 0d0accb36ff5c91daceb93bd8f7884caa738d38d6b0d3e015c96d4d943c5dc38},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41867086. Agents can read the archived copy with the MCP tool read_document.